Delivery Order SPE2DB20D3103-SPE2DB23FP5E8

Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Feraheme 510 mg/17 ml vials, a specialty pharmaceutical product. The delivery order has a ceiling value of $12,478.46 and a performance period through April 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation applied. This delivery order is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Feraheme (ferumoxytol) 510 mg/17 ml vials. The contract has a ceiling value of $22,761.88 and runs through May 11, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Feraheme, a 510 mg/17 ml vial pharmaceutical product, with a total ceiling value of $1,796.16 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the supply of Feraheme 510 mg/17 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,434.45, and has an ultimate completion date of December 26, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award is for the delivery of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $11,000.22 and a completion date of July 8, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,764.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2022, with a completion date of January 28, 2022. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This federal contract award, valued at $4,460.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Feraheme, a 510 mg/17 ml vial used for the treatment of iron deficiency anemia. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which has a ceiling value of $999,999,999...
This contract award (SPE2DB20D1109|SPE2DB21FP72A) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Feraheme 510 mg/17 ml vials. The contract, valued at $3,617.86, was awarded by the Defense Logistics Agency (DLA) on August 5, 2021, with an ultimate completion date of August 6, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,187.24 firm fixed-price contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP5E8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme (ferumoxytol) 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $29,382.18 and a period of performance through August 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order contract is part of the broader IDC and covers the procurement of the specialty medication Feraheme, which is used to treat iron deficiency anemia.

Generated 2/27/25, 12:43 PM